TGA Approval

IMJUDO tremelimumab 25 mg/ 1.25 mL concentrated injection vial (387299)

ARTG ID

387299

ARTG Name

IMJUDO tremelimumab 25 mg/ 1.25 mL concentrated injection vial

Sponsor

AstraZeneca Pty Ltd

ARTG Date

June 23, 2023

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

ASTRAZENECA PTY LTD

Ingredient Name

tremelimumab

Empowering clinical research with data-driven insights and AI-powered tools.

IMJUDO tremelimumab 25 mg/ 1.25 mL concentrated injection vial (387299) - TGA 批准文号 | MedPath